Whistleblower Protection Blog

Whistleblower Protection Blog

Advocating Whistleblower Rights for over Twenty Years

Monthly Archives: July 2010

Subscribe to Corporate Whistleblowers RSS Feed

Sixth Circuit says local officials are liable for statements that cause discharge

Posted in Corporate Whistleblowers, Government Whistleblowers
The Sixth Circuit U.S. Court of Appeals issued a decision this week that local government officials can be held liable for accusations they make against  citizens when it is "reasonably foreseeable" that their statements will cause the citizen to be fired from their job. Martha Paige worked as an accountant for Bunnell Hill Development Company in Warren County, Ohio. She… Continue Reading

CNBC notices whistleblower provisions of Dodd-Frank Act

Posted in Corporate Whistleblowers, False Claims / Qui Tam, Legislation, News
CNBC released a story yesterday about the qui tam provisions of the new Dodd-Frank Act, the financial reform law. They call the whistleblower provisions "little-noticed," indicating that we here at the National Whistleblowers Center (NWC) still need to do a better job of informing the media about new developments in whistleblower protection.  In the article, NWC Executive Director Stephen M.… Continue Reading

NWC letter to ARB explains how Dodd-Frank Act ices SOX subsidiary coverage

Posted in Corporate Whistleblowers, Department of Labor
Last week, I posted here an amicus brief for the U.S. Department of Labor’s Administrative Review Board (ARB) explaining how the Sarbanes-Oxley Act (SOX) protects corporate whistleblowers employed by the subsidiaries of publicly traded companies. What a difference a day makes. With President Obama’s signature today on the Dodd-Frank Wall Street Reform Act, SOX is now amended to explicitly protect… Continue Reading

Lawyers start assessing Dodd-Frank Act remedies

Posted in Corporate Whistleblowers, Department of Labor, False Claims / Qui Tam, Legislation
President Obama is scheduled to sign the Dodd-Frank Act tomorrow to enact the most significant reforms of our financial system in generations. Lawyers are already assessing some of those reforms, and we are focused on the new provisions for whistleblowers. My colleague, Lindsey Williams (Advocacy Director of the National Whistleblowers Center) already reported here on the substantive provisions of the… Continue Reading

Congress Passes Major Whistleblower Reforms as Part of Wall Street Reform Bill

Posted in Corporate Whistleblowers
The Wall Street Reform and Consumer Protection Act (H.R. 4173) passed 60-39 by Congress today includes a number of provisions designed to protect employees who report fraud in the commodity and stock exchanges. This is one of the most important whistleblower laws ever passed. The NWC has compiled the sections of this bill that pertain specifically to whistleblowers with a one-sentence summary of each...… Continue Reading

FDA whistleblower Dr. David Graham to testify on Avandia today

Posted in Pharmaceuticals
David J. Graham, M.D., M.P.H., is a drug safety whistleblower working at the Food and Drug Administration (FDA). On November 18, 2004, Dr. Graham testified before the U.S. Senate Committee on Finance about Merck’s withdrawal of the popular anti-inflammatory drug Vioxx. He testified that FDA policies could not protect the public from drugs with unacceptable risks. "I would argue that… Continue Reading

Aviation’s margin of safety, regulatory capture and FAA Whistleblowers Alliance

Posted in Corporate Whistleblowers, Government Whistleblowers, Images, Legislation, National Security
Two letters to the editor printed in today’s Washington Post reminded me of a meeting I attended in May of the FAA Whistleblowers Alliance. One of today’s letters was from the Potomac TRACON local of the National Air Traffic Controllers Association. The other letter, by FAA Administrator Randy Babbitt, extolled the virtues of the FAA’s Partnership for Safety program which… Continue Reading

Sen. Grassley asks pharma about whistleblower policies

Posted in Pharmaceuticals
Sen. Charles Grassley today released copies of his letters to 16 big pharmaceutical companies about their whistleblower policies. Bloomberg news service is also reporting on these inquiries. The letters review Sen. Grassley’s efforts to strengthen the False Claims Act (FCA), and ask what the companies are doing to inform employees about the FCA, and then to protect employees who come… Continue Reading